Tenaya Therapeutics (TNYA) Assets Average (2021 - 2026)
Tenaya Therapeutics (TNYA) posted quarterly Assets Average of $141.0 million for Q1 2026, up 6.86% year-over-year from $131.9 million in Q1 2025, and up 11.95% quarter-over-quarter from $126.0 million in Q4 2025.
Tenaya Therapeutics (TNYA) Assets Average (2021 - 2026) Analysis & Trends
Tenaya Therapeutics' Assets Average history runs 6 years deep, the most recent figure standing at $141.0 million for Q1 2026.
- In Q1 2026, Assets Average rose 6.86% year-over-year to $141.0 million; the TTM figure through Mar 2026 stood at $141.0 million (up 6.86% YoY), while the FY2025 annual figure was $133.4 million, down 8.12% from the prior year.
- Assets Average for Q1 2026 stood at $141.0 million, up from $126.0 million in the prior quarter.
- The five-year high for Assets Average was $297.8 million in Q1 2022, with the low at $113.6 million in Q3 2025.
- The 5-year median for Assets Average is $177.7 million (2024), against an average of $189.6 million.
- The sharpest annual moves came in 2024 and 2026: Assets Average sank 32.21% in 2024, then advanced 6.86% in 2026.
- Tenaya Therapeutics' Assets Average stood at $252.6 million in 2022, then decreased by 27.97% to $182.0 million in 2023, then fell by 28.41% to $130.3 million in 2024, then dropped by 3.31% to $126.0 million in 2025, then climbed by 11.95% to $141.0 million in 2026.
- Business Quant data shows TNYA's Assets Average at $141.0 million in Q1 2026, $126.0 million in Q4 2025, and $113.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 19.82 Bn |
| 10 | Tenaya Therapeutics | 152.74 Mn | 152.74 Mn | - | 114.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 114.31 Mn |
| Mar 31, 2026 | 141.00 Mn |
| Dec 31, 2025 | 125.95 Mn |
| Sep 30, 2025 | 113.57 Mn |
| Jun 30, 2025 | 133.05 Mn |
| Mar 31, 2025 | 131.95 Mn |
| Dec 31, 2024 | 130.26 Mn |
| Sep 30, 2024 | 151.88 Mn |
| Jun 30, 2024 | 174.04 Mn |
| Mar 31, 2024 | 177.71 Mn |
| Dec 31, 2023 | 181.96 Mn |
| Sep 30, 2023 | 207.08 Mn |
| Jun 30, 2023 | 233.05 Mn |
| Mar 31, 2023 | 262.14 Mn |
| Dec 31, 2022 | 252.63 Mn |
| Sep 30, 2022 | 241.12 Mn |
| Jun 30, 2022 | 268.71 Mn |
| Mar 31, 2022 | 297.84 Mn |
| Dec 31, 2021 | 322.99 Mn |
| Sep 30, 2021 | 244.34 Mn |